INS and obesity disorder: In mice with HFD-induced obesity, DW2010 induced AMP-activated protein kinase activation in the intestine and liver by inhibiting the gut microbiota and endotoxin production; furthermore, it suppressed body weight, hyperglycemia, epididymal fat, and insulin levels [18].